End-of-day quote
Shanghai S.E.
06:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
35.6
CNY
|
+1.57%
|
|
-4.71%
|
-10.19%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,000
|
23,347
|
16,679
|
14,979
|
-
|
-
|
Enterprise Value (EV)
1 |
26,000
|
23,347
|
16,679
|
14,979
|
14,979
|
14,979
|
P/E ratio
|
39
x
|
18.6
x
|
31.7
x
|
17.9
x
|
14.3
x
|
11.5
x
|
Yield
|
0.48%
|
0.64%
|
1.77%
|
1.4%
|
1.27%
|
1.4%
|
Capitalization / Revenue
|
1.67
x
|
0.81
x
|
0.96
x
|
0.78
x
|
0.65
x
|
0.57
x
|
EV / Revenue
|
1.67
x
|
0.81
x
|
0.96
x
|
0.78
x
|
0.65
x
|
0.57
x
|
EV / EBITDA
|
-
|
15.1
x
|
18.1
x
|
10.9
x
|
9
x
|
7.34
x
|
EV / FCF
|
-209
x
|
-10.6
x
|
11.6
x
|
65.4
x
|
-13.7
x
|
-
|
FCF Yield
|
-0.48%
|
-9.47%
|
8.6%
|
1.53%
|
-7.32%
|
-
|
Price to Book
|
6.96
x
|
2.85
x
|
1.94
x
|
1.63
x
|
1.47
x
|
1.35
x
|
Nbr of stocks (in thousands)
|
352,201
|
420,771
|
420,771
|
420,771
|
-
|
-
|
Reference price
2 |
73.82
|
55.49
|
39.64
|
35.60
|
35.60
|
35.60
|
Announcement Date
|
1/25/22
|
1/19/23
|
1/17/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
15,566
|
28,751
|
17,311
|
19,309
|
22,998
|
26,331
|
EBITDA
1 |
-
|
-
|
1,542
|
922.5
|
1,373
|
1,665
|
2,042
|
EBIT
1 |
-
|
617.5
|
1,240
|
560.4
|
903.2
|
1,143
|
1,402
|
Operating Margin
|
-
|
3.97%
|
4.31%
|
3.24%
|
4.68%
|
4.97%
|
5.33%
|
Earnings before Tax (EBT)
1 |
-
|
612.9
|
1,241
|
558.6
|
903
|
1,143
|
1,402
|
Net income
1 |
250.5
|
555.3
|
1,121
|
527.5
|
838.8
|
1,051
|
1,307
|
Net margin
|
-
|
3.57%
|
3.9%
|
3.05%
|
4.34%
|
4.57%
|
4.96%
|
EPS
2 |
0.9714
|
1.893
|
2.986
|
1.250
|
1.994
|
2.496
|
3.107
|
Free Cash Flow
1 |
-
|
-124.2
|
-2,212
|
1,435
|
229
|
-1,097
|
-
|
FCF margin
|
-
|
-0.8%
|
-7.69%
|
8.29%
|
1.19%
|
-4.77%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
155.55%
|
16.68%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
272.05%
|
27.3%
|
-
|
-
|
Dividend per Share
2 |
-
|
0.3571
|
0.3571
|
0.7000
|
0.5000
|
0.4533
|
0.5000
|
Announcement Date
|
7/18/21
|
1/25/22
|
1/19/23
|
1/17/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-124
|
-2,212
|
1,435
|
229
|
-1,097
|
-
|
ROE (net income / shareholders' equity)
|
-
|
18.7%
|
20.9%
|
6.3%
|
9.15%
|
10.6%
|
12%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
4.79%
|
5.94%
|
7.73%
|
Assets
1 |
-
|
-
|
-
|
-
|
17,512
|
17,697
|
16,904
|
Book Value Per Share
2 |
-
|
10.60
|
19.50
|
20.40
|
21.80
|
24.20
|
26.30
|
Cash Flow per Share
2 |
-
|
-
|
-3.710
|
6.130
|
2.760
|
3.150
|
3.070
|
Capex
1 |
-
|
556
|
651
|
1,145
|
1,254
|
1,330
|
397
|
Capex / Sales
|
-
|
3.57%
|
2.26%
|
6.62%
|
6.49%
|
5.79%
|
1.51%
|
Announcement Date
|
7/18/21
|
1/25/22
|
1/19/23
|
1/17/24
|
-
|
-
|
-
|
Last Close Price
35.6
CNY Average target price
38.47
CNY Spread / Average Target +8.06% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.19% | 2.04B | | +17.80% | 66.43B | | +2.92% | 49.89B | | +19.98% | 41.88B | | +20.88% | 26.48B | | +12.04% | 19.68B | | +1.27% | 17B | | -22.98% | 16.12B | | +2.77% | 15.28B | | -9.25% | 15.18B |
Other Specialty Chemicals
|